Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $100,680 | 173 | 88.4% |
| Food and Beverage | $12,922 | 832 | 11.3% |
| Education | $295.26 | 12 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $100,680 | 173 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $2,084 | 60 | $0 (2024) |
| PFIZER INC. | $1,782 | 139 | $0 (2024) |
| Novo Nordisk Inc | $1,167 | 94 | $0 (2024) |
| Amgen Inc. | $1,033 | 75 | $0 (2024) |
| ABBVIE INC. | $809.36 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $641.77 | 46 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $572.71 | 68 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $549.00 | 36 | $0 (2024) |
| Lilly USA, LLC | $536.99 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,160 | 129 | ABBVIE INC. ($431.48) |
| 2023 | $1,887 | 113 | AbbVie Inc. ($323.54) |
| 2022 | $1,545 | 98 | Amgen Inc. ($255.58) |
| 2021 | $10,648 | 90 | CSL Behring ($9,360) |
| 2020 | $16,880 | 62 | CSL Behring ($16,240) |
| 2019 | $26,867 | 176 | CSL Behring ($25,240) |
| 2018 | $26,057 | 170 | CSL Behring ($24,080) |
| 2017 | $27,853 | 179 | CSL Behring ($25,760) |
All Payment Transactions
1,017 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: VACCINES | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: ANTIBIOTIC | ||||||
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: PAIN | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.68 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 696 | 1,113 | $243,718 | $84,673 |
| 2022 | 21 | 1,705 | 2,362 | $296,654 | $119,775 |
| 2021 | 21 | 1,993 | 3,028 | $355,769 | $157,344 |
| 2020 | 25 | 2,017 | 3,111 | $353,438 | $134,839 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 297 | 684 | $171,492 | $55,237 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 151 | 151 | $39,164 | $18,454 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 87 | $14,964 | $4,882 | 32.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $4,620 | $1,841 | 39.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 22 | 22 | $3,652 | $1,668 | 45.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 26 | 30 | $5,034 | $945.48 | 18.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 26 | $1,019 | $743.60 | 73.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 25 | 29 | $1,276 | $481.98 | 37.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 19 | $1,121 | $180.76 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 20 | $650.00 | $168.00 | 25.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 33 | $726.00 | $72.60 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 394 | 700 | $151,240 | $53,292 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 314 | 314 | $72,855 | $38,664 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 192 | $28,999 | $10,549 | 36.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 58 | 59 | $8,232 | $4,041 | 49.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 19 | 19 | $6,018 | $2,867 | 47.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 390 | 692 | $8,321 | $2,046 | 24.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 65 | 66 | $3,678 | $1,779 | 48.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 37 | 40 | $4,026 | $1,515 | 37.6% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 34 | 34 | $2,720 | $1,212 | 44.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 17 | 18 | $1,530 | $592.93 | 38.8% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 15 | 15 | $1,200 | $539.77 | 45.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 26 | 26 | $1,456 | $532.69 | 36.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 14 | 14 | $998.00 | $424.79 | 42.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $950.00 | $383.89 | 40.4% |
About Dr. Robert Sasser, MD
Dr. Robert Sasser, MD is a Internal Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891889929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sasser, MD has received a total of $113,897 in payments from pharmaceutical and medical device companies, with $2,160 received in 2024. These payments were reported across 1,017 transactions from 50 companies. The most common payment nature is "Consulting Fee" ($100,680).
As a Medicare-enrolled provider, Sasser has provided services to 6,411 Medicare beneficiaries, totaling 9,614 services with total Medicare billing of $496,632. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Louisville, KY
- Active Since 10/03/2006
- Last Updated 12/02/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891889929
Products in Payments
- ELIQUIS (Drug) $728.48
- FARXIGA (Drug) $725.92
- Otezla (Drug) $695.44
- VRAYLAR (Drug) $584.10
- Ozempic (Drug) $549.38
- XARELTO (Drug) $534.96
- ENTRESTO (Drug) $472.33
- CHANTIX (Drug) $399.80
- JARDIANCE (Drug) $367.26
- BREZTRI (Drug) $299.07
- NURTEC ODT (Drug) $278.64
- BEVESPI AEROSPHERE (Drug) $275.22
- MOVANTIK (Drug) $271.97
- Kerendia (Drug) $240.69
- Vascepa (Drug) $239.03
- SOLIQUA 100/33 (Biological) $234.57
- VOQUEZNA (Drug) $212.84
- Aimovig (Biological) $212.20
- FASENRA (Biological) $204.55
- RELISTOR (Drug) $200.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Hisham Alrefai, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400